<DOC>
	<DOCNO>NCT01194401</DOCNO>
	<brief_summary>This prospective , multi-center observational study ass long-term efficacy safety RoActemra/Actemra daily practice patient active moderate severe rheumatoid arthritis inadequate response intolerant one disease-modifying antirheumatic drug ( DMARDs ) tumour necrosis factor ( TNF ) antagonists . Data collect patient initiated RoActemra/Actemra treatment accord label decision treat physician . Anticipated time data collection patient 2 year .</brief_summary>
	<brief_title>An Observational Study Long-Term Effectiveness Safety RoActemra/Actemra ( Tocilizumab ) Daily Practice Patients With Rheumatoid Arthritis ( ICHIBAN )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Active moderate severe rheumatoid arthritis Inadequate response intolerant previous therapy one diseasemodifying antirheumatic drug ( DMARDs ) tumour necrosis factor ( TNF ) antagonists Prescription RoActemra/Actemra accord label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>